These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9849585)

  • 1. In vivo efficacy and tumor-selective metabolism of amrubicin to its active metabolite.
    Noguchi T; Ichii S; Morisada S; Yamaoka T; Yanagi Y
    Jpn J Cancer Res; 1998 Oct; 89(10):1055-60. PubMed ID: 9849585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-selective distribution of an active metabolite of the 9-aminoanthracycline amrubicin.
    Noguchi T; Ichii S; Morisada S; Yamaoka T; Yanagi Y
    Jpn J Cancer Res; 1998 Oct; 89(10):1061-6. PubMed ID: 9849586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and intracellular distribution of amrubicin, a novel 9-amino-anthracycline, and its active metabolite amrubicinol in P388 murine leukemia cells.
    Yamaoka T; Hanada M; Ichii S; Morisada S; Noguchi T; Yanagi Y
    Jpn J Cancer Res; 1999 Jun; 90(6):685-90. PubMed ID: 10429662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its active metabolite amrubicinol on human tumor cells.
    Yamaoka T; Hanada M; Ichii S; Morisada S; Noguchi T; Yanagi Y
    Jpn J Cancer Res; 1998 Oct; 89(10):1067-73. PubMed ID: 9849587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of amrubicin with a 5 day administration schedule in a mouse model].
    Noguchi T; Ichii S; Morisada S; Yamaoka T; Yanagi Y
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1305-12. PubMed ID: 10478184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Profile of the anti-tumor effects of amrubicin, a completely synthetic anthracycline].
    Hanada M; Noguchi T; Murayama T
    Nihon Yakurigaku Zasshi; 2003 Aug; 122(2):141-50. PubMed ID: 12890900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.
    Hanada M; Noguchi T; Yamaoka T
    Cancer Sci; 2007 Mar; 98(3):447-54. PubMed ID: 17214744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of amrubicin and its active metabolite amrubicinol in lung cancer patients.
    Matsunaga Y; Hamada A; Okamoto I; Sasaki J; Moriyama E; Kishi H; Matsumoto M; Hira A; Watanabe H; Saito H
    Ther Drug Monit; 2006 Feb; 28(1):76-82. PubMed ID: 16418698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic study on amrubicin and amrubicinol in Japanese patients with lung cancer.
    Makino Y; Yamamoto N; Sato H; Ando R; Goto Y; Tanai C; Asahina H; Nokihara H; Sekine I; Kunitoh H; Ohe Y; Sugiyama E; Yokote N; Tamura T; Yamamoto H
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):861-9. PubMed ID: 22042514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells.
    Hira A; Watanabe H; Maeda Y; Yokoo K; Sanematsu E; Fujii J; Sasaki J; Hamada A; Saito H
    Biochem Pharmacol; 2008 Feb; 75(4):973-80. PubMed ID: 18054347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of combination treatment and influence of schedule with irinotecan and amrubicin in human lung carcinoma cells in vivo and in vitro.
    Shishido Y; Furuta T; Matsuzaki T; Nagata H; Hashimoto S
    Biol Pharm Bull; 2010; 33(7):1183-91. PubMed ID: 20606311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-antitumor activity relationship of semi-synthetic spicamycin analogues.
    Kamishohara M; Kawai H; Odagawa A; Isoe T; Mochizuki J; Uchida T; Hayakawa Y; Seto H; Tsuruo T; Otake N
    J Antibiot (Tokyo); 1993 Sep; 46(9):1439-46. PubMed ID: 8226322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amrubicin induces apoptosis in human tumor cells mediated by the activation of caspase-3/7 preceding a loss of mitochondrial membrane potential.
    Hanada M; Noguchi T; Yamaoka T
    Cancer Sci; 2006 Dec; 97(12):1396-403. PubMed ID: 16995876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual optimal dose of amrubicin to prevent severe neutropenia in Japanese patients with lung cancer.
    Makino Y; Makihara-Ando R; Ogawa T; Sato H; Goto Y; Kanda S; Horinouchi H; Fujiwara Y; Ohe Y; Yamamoto N
    Cancer Sci; 2019 Nov; 110(11):3573-3583. PubMed ID: 31505087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicin.
    Takakuwa O; Oguri T; Ozasa H; Uemura T; Kunii E; Kasai D; Miyazaki M; Maeno K; Sato S
    J Thorac Oncol; 2011 Nov; 6(11):1826-32. PubMed ID: 21964527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
    McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
    Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of amrubicin with cisplatin on human lung cancer cell lines.
    Yamauchi S; Kudoh S; Kimura T; Hirata K; Yoshikawa J
    Osaka City Med J; 2002 Jun; 48(1):69-76. PubMed ID: 12375699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic study of amrubicin in a case of small lung cancer on hemodialysis].
    Ohsawa M; Demizu M; Chihara S; Ueda H; Igarashi T; Tomiyama N; Nakashima Y; Hosoi K; Min K
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1311-4. PubMed ID: 19692770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.